Latest Insider Transactions at Hca Healthcare, Inc. (HCA)
This section provides a real-time view of insider transactions for Hca Healthcare, Inc. (HCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HCA Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HCA Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
BUY
Exercise of conversion of derivative security
|
Direct |
7,037
+18.94%
|
$752,959
$107.39 P/Share
|
|
Nov 16
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Open market or private sale
|
Direct |
5,078
-48.08%
|
$766,778
$151.75 P/Share
|
|
Nov 16
2020
|
J William Morrow SVP - Finance and Treasurer |
SELL
Bona fide gift
|
Direct |
117
-8.62%
|
-
|
|
Nov 16
2020
|
J William Morrow SVP - Finance and Treasurer |
SELL
Open market or private sale
|
Direct |
7,868
-85.28%
|
$1,188,068
$151.75 P/Share
|
|
Nov 16
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
3,770
-100.0%
|
$569,270
$151.75 P/Share
|
|
Nov 16
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,257
-51.97%
|
$3,662,807
$151.82 P/Share
|
|
Nov 16
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,750
+48.95%
|
$1,655,750
$37.18 P/Share
|
|
Nov 13
2020
|
J William Morrow SVP - Finance and Treasurer |
SELL
Open market or private sale
|
Direct |
1,350
-12.76%
|
$201,150
$149.75 P/Share
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
319
-7.8%
|
$47,531
$149.47 P/Share
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Indirect |
127,999
+50.0%
|
-
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Indirect |
63,999
-100.0%
|
-
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Direct |
64,000
-93.99%
|
-
|
|
Nov 13
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Open market or private sale
|
Direct |
17,002
-89.82%
|
$2,533,298
$149.5 P/Share
|
|
Nov 13
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Indirect |
7,802
+11.89%
|
-
|
|
Nov 13
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Indirect |
7,802
-100.0%
|
-
|
|
Nov 12
2020
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Direct |
64,000
+48.45%
|
-
|
|
Nov 12
2020
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Indirect |
64,000
-50.0%
|
-
|
|
Nov 11
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Indirect |
15,604
+30.95%
|
-
|
|
Nov 11
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Direct |
15,604
-25.89%
|
-
|
|
Nov 10
2020
|
Jon M Foster EVP and COO |
BUY
Bona fide gift
|
Indirect |
34,039
+43.6%
|
-
|
|
Nov 10
2020
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Indirect |
34,039
-100.0%
|
-
|
|
Nov 10
2020
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
6,536
-3.16%
|
$1,006,544
$154.46 P/Share
|
|
Nov 09
2020
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,911
-59.11%
|
$868,917
$147.32 P/Share
|
|
Nov 09
2020
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$470,000
$47.97 P/Share
|
|
Nov 09
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,498
-37.25%
|
$3,013,206
$147.32 P/Share
|
|
Nov 09
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+40.53%
|
$1,387,500
$37.18 P/Share
|
|
Nov 09
2020
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
3,490
-29.07%
|
$520,010
$149.75 P/Share
|
|
Nov 09
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
3,948
-100.0%
|
$584,304
$148.07 P/Share
|
|
Nov 09
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Open market or private sale
|
Direct |
5,531
-23.98%
|
$813,057
$147.36 P/Share
|
|
Nov 06
2020
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
250
-1.34%
|
-
|
|
Nov 05
2020
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Open market or private sale
|
Direct |
3,472
-71.63%
|
$482,608
$139.19 P/Share
|
|
Nov 05
2020
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
1,745
-19.96%
|
$242,555
$139.5 P/Share
|
|
Nov 05
2020
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
15,000
-6.52%
|
$2,085,000
$139.36 P/Share
|
|
Nov 05
2020
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,052
-60.52%
|
$829,124
$137.56 P/Share
|
|
Nov 05
2020
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$470,000
$47.97 P/Share
|
|
Nov 05
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,969
-23.21%
|
$954,753
$137.56 P/Share
|
|
Nov 05
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+29.39%
|
$462,500
$37.18 P/Share
|
|
Nov 05
2020
|
Bill B Rutherford CFO and EVP |
SELL
Open market or private sale
|
Direct |
36,250
-66.02%
|
$5,038,750
$139.33 P/Share
|
|
Nov 05
2020
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+9.74%
|
$236,250
$21.73 P/Share
|
|
Nov 04
2020
|
Jon M Foster EVP and COO |
BUY
Bona fide gift
|
Indirect |
68,078
+46.8%
|
-
|
|
Nov 04
2020
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Direct |
68,078
-75.0%
|
-
|
|
Nov 03
2020
|
Samuel N Hazen CEO |
SELL
Open market or private sale
|
Direct |
121,875
-11.42%
|
$16,453,125
$135.85 P/Share
|
|
Nov 03
2020
|
Samuel N Hazen CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
227,540
-36.83%
|
$30,945,440
$136.09 P/Share
|
|
Nov 03
2020
|
Samuel N Hazen CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
557,125
+22.45%
|
$13,371,000
$24.18 P/Share
|
|
Nov 03
2020
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
34,061
-43.83%
|
$4,632,296
$136.09 P/Share
|
|
Nov 03
2020
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
66,575
+31.28%
|
$1,997,250
$30.07 P/Share
|
|
Nov 03
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
1,771
-100.0%
|
$235,543
$133.5 P/Share
|
|
Nov 02
2020
|
Sandra L. Morgan SVP-Provider Relations |
SELL
Open market or private sale
|
Direct |
5,030
-47.33%
|
$638,810
$127.75 P/Share
|
|
Oct 30
2020
|
Charles J Hall Group President |
SELL
Bona fide gift
|
Direct |
8,150
-3.79%
|
-
|
|
Oct 29
2020
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
1,268
-24.24%
|
$157,232
$124.41 P/Share
|